SIC 2836 – Biological Products, Except Diagnostic Substances (Biotech)
| Valuation | |
|---|---|
| Market Cap ($M) | 22,694.22 |
| Enterprise Value ($M) | 21,194.28 |
| Book Value ($M) | 5,498.28 |
| Book Value / Share | 90.49 |
| Price / Book | 4.13 |
| NCAV ($M) | 4,178.86 |
| NCAV / Share | 68.78 |
| Price / NCAV | 5.43 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | 0.15 |
| Return on Assets (ROA) | 0.18 |
| Return on Equity (ROE) | 0.20 |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 6.68 |
| Current Ratio | 7.29 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 4,883.10 |
| Assets | 6,202.52 |
| Liabilities | 704.24 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 2,252.04 |
| Operating Income | -14.01 |
| Net Income | 833.04 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | -82.75 |
| Cash from Investing | -717.59 |
| Cash from Financing | 279.76 |
(click for more detail) |
|
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| Similar Companies | |
|---|---|
| AOLS – Aeolus Pharmaceuticals, Inc. | AOXG – Aoxing Pharmaceutical Company, Inc. |
| ARDS – Aridis Pharmaceuticals, Inc. | ARNI – Arno Therapeutics, Inc. |
| ARSUF – Fagron NV |
Financial data and stock pages provided by
Fintel.io